CN108835321A - 一种抗癌、抗肿瘤的生态富硒发酵饮料 - Google Patents
一种抗癌、抗肿瘤的生态富硒发酵饮料 Download PDFInfo
- Publication number
- CN108835321A CN108835321A CN201810855024.3A CN201810855024A CN108835321A CN 108835321 A CN108835321 A CN 108835321A CN 201810855024 A CN201810855024 A CN 201810855024A CN 108835321 A CN108835321 A CN 108835321A
- Authority
- CN
- China
- Prior art keywords
- anticancer
- ecological
- selenium
- antitumor
- bacterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 title claims abstract description 52
- 239000011669 selenium Substances 0.000 title claims abstract description 40
- 229910052711 selenium Inorganic materials 0.000 title claims abstract description 37
- 230000001093 anti-cancer Effects 0.000 title claims abstract description 36
- 238000000855 fermentation Methods 0.000 title claims abstract description 32
- 230000004151 fermentation Effects 0.000 title claims abstract description 32
- 230000000259 anti-tumor effect Effects 0.000 title claims abstract description 30
- 235000013361 beverage Nutrition 0.000 title claims abstract description 25
- 240000000588 Hericium erinaceus Species 0.000 claims abstract description 24
- 235000007328 Hericium erinaceus Nutrition 0.000 claims abstract description 24
- 241000894006 Bacteria Species 0.000 claims abstract description 21
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims abstract description 20
- 235000011430 Malus pumila Nutrition 0.000 claims abstract description 20
- 235000015103 Malus silvestris Nutrition 0.000 claims abstract description 20
- 241000609666 Tuber aestivum Species 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 14
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 14
- 244000000626 Daucus carota Species 0.000 claims abstract description 14
- 244000197580 Poria cocos Species 0.000 claims abstract description 14
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 14
- 241001486992 Taiwanofungus camphoratus Species 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims abstract description 14
- 235000002767 Daucus carota Nutrition 0.000 claims abstract description 13
- 244000068988 Glycine max Species 0.000 claims abstract description 13
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 13
- 241000222684 Grifola Species 0.000 claims abstract description 13
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims abstract description 13
- 235000014443 Pyrus communis Nutrition 0.000 claims abstract description 13
- 206010028980 Neoplasm Diseases 0.000 claims description 8
- 239000002304 perfume Substances 0.000 claims description 4
- 235000013599 spices Nutrition 0.000 claims description 4
- 241000227653 Lycopersicon Species 0.000 claims 4
- 241000234295 Musa Species 0.000 claims 4
- 241000282693 Cercopithecidae Species 0.000 claims 1
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims 1
- 241000382353 Pupa Species 0.000 claims 1
- 235000019985 fermented beverage Nutrition 0.000 claims 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims 1
- 239000010931 gold Substances 0.000 claims 1
- 229910052737 gold Inorganic materials 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 29
- 240000003768 Solanum lycopersicum Species 0.000 abstract description 16
- 230000036541 health Effects 0.000 abstract description 13
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract description 9
- 206010020772 Hypertension Diseases 0.000 abstract description 9
- 240000008790 Musa x paradisiaca Species 0.000 abstract description 9
- 201000001421 hyperglycemia Diseases 0.000 abstract description 9
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 7
- 239000007788 liquid Substances 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 5
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 5
- 238000002360 preparation method Methods 0.000 abstract description 4
- 230000001954 sterilising effect Effects 0.000 abstract description 4
- 238000001914 filtration Methods 0.000 abstract description 2
- 239000011521 glass Substances 0.000 abstract description 2
- 230000005484 gravity Effects 0.000 abstract description 2
- 238000002156 mixing Methods 0.000 abstract description 2
- 238000004806 packaging method and process Methods 0.000 abstract description 2
- 238000012545 processing Methods 0.000 abstract description 2
- 235000011649 selenium Nutrition 0.000 description 27
- 239000003814 drug Substances 0.000 description 12
- 241000282414 Homo sapiens Species 0.000 description 9
- 244000269722 Thea sinensis Species 0.000 description 9
- 201000011510 cancer Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 208000007107 Stomach Ulcer Diseases 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 208000000718 duodenal ulcer Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 201000005917 gastric ulcer Diseases 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- QGXBDMJGAMFCBF-HLUDHZFRSA-N 5α-Androsterone Chemical compound C1[C@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 QGXBDMJGAMFCBF-HLUDHZFRSA-N 0.000 description 2
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 235000011511 Diospyros Nutrition 0.000 description 2
- 244000236655 Diospyros kaki Species 0.000 description 2
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 2
- QGXBDMJGAMFCBF-UHFFFAOYSA-N Etiocholanolone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC21 QGXBDMJGAMFCBF-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 229940061641 androsterone Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- -1 multivitamin Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- JSPNNZKWADNWHI-PNANGNLXSA-N (2r)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]heptadecanamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@H]([C@H](O)\C=C\CC\C=C(/C)CCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JSPNNZKWADNWHI-PNANGNLXSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical group C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000123370 Antrodia Species 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008428 Chemical poisoning Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 208000020401 Depressive disease Diseases 0.000 description 1
- 235000002722 Dioscorea batatas Nutrition 0.000 description 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000060234 Gmelina philippensis Species 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000577951 Hydnum Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000022535 Infectious Skin disease Diseases 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 241000149440 Lentinus tuber-regium Species 0.000 description 1
- 229930192392 Mitomycin Natural products 0.000 description 1
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000356847 Otolithes Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010039921 Selenium deficiency Diseases 0.000 description 1
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 description 1
- RJFAYQIBOAGBLC-UHFFFAOYSA-N Selenomethionine Natural products C[Se]CCC(N)C(O)=O RJFAYQIBOAGBLC-UHFFFAOYSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 201000006559 Vertebrobasilar insufficiency Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000002205 anti-dementic effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 235000005770 birds nest Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 230000007541 cellular toxicity Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 229930183167 cerebroside Natural products 0.000 description 1
- RIZIAUKTHDLMQX-UHFFFAOYSA-N cerebroside D Natural products CCCCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O RIZIAUKTHDLMQX-UHFFFAOYSA-N 0.000 description 1
- 210000004720 cerebrum Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- GGCLNOIGPMGLDB-GYKMGIIDSA-N cholest-5-en-3-one Chemical compound C1C=C2CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 GGCLNOIGPMGLDB-GYKMGIIDSA-N 0.000 description 1
- NYOXRYYXRWJDKP-UHFFFAOYSA-N cholestenone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 NYOXRYYXRWJDKP-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000014106 fortified food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 208000001130 gallstones Diseases 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000006882 induction of apoptosis Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 238000002803 maceration Methods 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 230000002842 otolith Effects 0.000 description 1
- 210000001265 otolithic membrane Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 229960002718 selenomethionine Drugs 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000005765 wild carrot Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/166—Addition of, or treatment with, enzymes or microorganisms
Abstract
本发明属于保健饮品技术领域，公开了一种抗癌、抗肿瘤的生态富硒发酵饮料，组份按质量计由有机生态硒粉、茶叶、牛樟芝、金藏花、灰树花、茯苓、玉竹、松露、蛹虫草、大豆、虎菌、猴头菌、蜜环菌、香菇、苹果、梨子、香蕉、橙子、胡萝卜、西红柿、黑糖及水组成；制备方法包括混合，将所有材料按比例混合；装罐，将混合物放入高位罐加入常温纯净水；发酵，让产品经过六个月的发酵处理；过滤，将残渣排除，只留下发酵液；杀菌，将发酵液进行杀菌处理；包装，将发酵液装入玻璃瓶封口、打包。本发明具有抗癌、抗肿瘤、降三高、抗氧化保健功效。
Description
技术领域
本发明属于保健饮品技术领域，尤其涉及一种抗癌、抗肿瘤的生态富硒发酵饮料。
背景技术
目前，业内常用的现有技术是这样的：
硒是人体必需的微量元素，硒和维生素E、β-胡萝卜素搭配可以增强人体免疫功能、抗氧化、延缓衰老，富硒食品有抗癌，抗辐射等作用，能有效抑制肿瘤生长，对手术和放化疗治疗后的患者有很好的辅助改善作用。
而硒在地球表面分布是极不平衡的，我国约有72%地区缺硒，特别是从东北到西南的15个省市自治区的部分地区构成了“贫硒地带”。导致很多人在日常摄取的硒含量较低，导致摄取量不足，因此需要通过有效的方法增加日常食品中的含硒量。硒又分为植物活性硒和无机硒两种，无机硒有较大的毒性，且不易被吸收，不适合人和动物使用。植物活性硒通过生物转化与氨基酸结合而成，一般以硒蛋氨酸的形式存在，植物活性硒是人类和动物允许使用的硒源。
综上所述，现有技术存在的问题是：
（1）人们在日常摄取的硒含量不足，市场上缺少一种利用有机生态硒粉及中草药和有益菌制作食物饮品，来为人们抗癌、抗肿瘤、降三高、抗氧化提供帮助。
解决上述技术问题的难度和意义：
本发明具有抗癌、抗肿瘤、降三高、抗氧化保健功效。
发明内容
针对现有技术存在的问题，本发明提供了一种抗癌、抗肿瘤的生态富硒发酵饮料。
本发明是这样实现的，一种抗癌、抗肿瘤的生态富硒发酵饮料，组份按质量计由有机生态硒粉0.25~1 KG、茶叶0.5~2Kg、牛樟芝0.25~1 KG、金藏花0.25~1 KG、灰树花0.25~1KG、茯苓0.5~2.5 KG、玉竹0.5~5 KG、松露0.25~1.5 KG、蛹虫草0.5~2.5 KG、大豆0.5~2.5KG、虎菌0.5-6 KG、猴头菌0.5~2.5 KG、蜜环菌0.5~4 KG、香菇0.5~2.5 KG、苹果0.5~15 KG、梨子0.5~15 KG、香蕉0.5~10 KG、橙子0.5~10 KG、胡萝卜0.5~5 KG、西红柿0.5~5 KG、黑糖0.5~10 KG及水100KG组成。
进一步，所述抗癌、抗肿瘤的生态富硒发酵饮料的组份按质量计由
有机生态硒粉0.25KG、牛樟芝0.25KG、金藏花0.25KG、灰树花0.25KG、茯苓0.5 KG、玉竹0.5KG、松露0.25KG、蛹虫草0.5 KG、大豆0.5KG、虎菌0.5KG、猴头菌0.5 KG、蜜环菌0.5KG、香菇0.5 KG、苹果0.5KG、梨子0.5 KG、香蕉0.5 KG、橙子0.5 KG、胡萝卜0.5KG、西红柿0.5 KG、黑糖0.5 KG及水100KG组成。
进一步，所述抗癌、抗肿瘤的生态富硒发酵饮料的组份按质量计由有机生态硒粉1KG、牛樟芝1 KG、金藏花1 KG、灰树花1 KG、茯苓2.5 KG、玉竹5 KG、松露01.5 KG、蛹虫草2.5KG、大豆2.5 KG、虎菌6 KG、猴头菌2.5 KG、蜜环菌4 KG、香菇2.5 KG、苹果15 KG、梨子15KG、香蕉10 KG、橙子10 KG、胡萝卜5 KG、西红柿5 KG、黑糖10 KG及水100KG组成。
进一步，所述抗癌、抗肿瘤的生态富硒发酵饮料的组份按质量计由有机生态硒粉0.75 KG、牛樟芝0.50 KG、金藏花0.65 KG、灰树花0.65KG、茯苓1.5 KG、玉竹2.5KG、松露1.0KG、蛹虫草1.5 KG、大豆1.5KG、虎菌3.5 KG、猴头菌1.5KG、蜜环菌2.5 KG、香菇1.5 KG、苹果10KG、梨子10 KG、香蕉5.5KG、橙子6.5KG、胡萝卜2.5KG、西红柿2.5KG、黑糖6.5 KG及水100KG组成。
综上所述，本发明的优点及积极效果为：
本发明具有抗癌、抗肿瘤、降三高、抗氧化保健功效。本发明的牛樟芝极品多醣液的功效作用，解毒:视樟芝被视为解毒剂,凡食物中毒、腹泻、呕吐、农药中毒均具有解毒作用；
金藏花广泛适用于任何肤质,不但能够清洁、均衡、活化、调理肌肤,并且有助于青春痘疤痕之愈合；
灰树花的防癌抗癌作用：
1.活化吞噬细胞、自然杀手细胞、伤害性T细胞等免疫细胞，诱导白细胞素，干扰素-γ，肿瘤坏死因子-α等细胞因子的分泌。
2.诱导癌细胞凋亡。
3.与传统的化学治疗药物(丝裂霉素、卡莫斯丁等)合用，既增加药效，又减轻化疗过程中的毒副作用。
4.与免疫治疗药物(干扰素-α2b)有协同作用。
5.减缓晚期癌症患者的疼痛，增加食欲，改善患者的生活质量。
茯苓宁静作用减弱,导致肾阳偏盛,甚至虚火上炎,所以用"三补"熟地、山萸、山药大补肝脾肾三脏；
玉竹有滋养、镇静及强心作用,适用于治疗心悸、心绞痛;玉竹有降低血脂和血糖作用
松露含有丰富的蛋白质、 18种氨基酸(包括人体不能合成的8种必需氨基酸)、不饱和脂肪酸、多种维生素、锌、锰、铁、钙、磷、硒等必需微量元素，以及鞘脂类、脑苷脂、神经酰胺、三萜、雄性酮、腺苷、松露酸、甾醇、松露多糖、松露多肽等大量的代谢产物，具有极高的营养保健价值。其中雄性酮有助阳、调理内分泌的显著功效；鞘脂类化合物在防止老年痴呆、动脉粥样硬化以及抗肿瘤细胞毒性方面有明显活性；多糖、多肽、三萜具有增强免疫力、抗衰老、抗疲劳等作用，可用于保健养身。
蛹虫草的功效：补肺阴、补肾阳，蛹虫草的作用是治肾虚，阳萎遗精，腰膝酸痛，病后虚弱。中医认为其起扶正固本作用，对老年性慢性支气管炎、肺原性心脏病有显著疗效，能提高肝脏解毒能力，起护肝作用，提高身体抗病毒和抗辐射能力。
本发明的茶叶冲调保健。茶叶中含有儿茶素、胆甾烯酮、咖啡碱、肌醇、叶酸、泛酸等成分，可以增进人体健康。茶叶饮品-茶被誉为"世界三大饮料之一。
由于茶叶有很好的医疗效用，所以唐代即有“茶药”（见代宗大历十四年王国题写的“茶药”）一词；宋代林洪撰的《山家清供》中，也有“茶，即药也”的论断。可见，茶就是药，并为药书（古称本草）所收载，道通天下。但近代的习惯，“茶药”一词则仅限于方中含有茶叶的制剂。由于茶叶有很多的功效，可以防、治内外妇儿各科的很多病症，所以，茶不但是药，而目是如同唐代陈藏器所强调的：“茶为万病之药”。茶中含有的茶多酚，具有很强的抗氧化性和生理活性，是人体自由基的清除剂，可以阻断亚硝酸胺等多种致癌物质在体内合成。它还能吸收放射性物质达到防辐射的效果，从而保护女性皮肤。用茶叶洗脸，还能清除面部的油腻、收敛毛孔、减缓皮肤老化。
茶不但有对多科疾病的治疗效能，而且有良好的延年益寿、抗老强身的作用。
本发明的茶叶具有二十三功效：
(1)少睡 (2)安神 (3)明目 (4)清头目 (5)止渴生津 (6)清热 (7)消暑 (8)解毒 (9)消食 (10)醒酒 (11)去减肥 (12)下气 (13)利水 (14)通便 (15)治痢 (16)去痰 (17)祛风解表 (18)坚齿 (19)治心痛 (20)疗疮治瘘 (21)疗饥 (22)益气力 (23)延年益寿。
本发明的苹果含有较多的钾，能与人体过剩的钠盐结合，使之排出体外。当人体摄入钠盐过多时，苹果有利于平衡体内电解质。苹果中含有的磷和铁等元素，易被肠壁吸收，有补脑养血、宁神安眠作用。苹果的香气是治疗抑郁和压抑感的良药。本发明的苹果还具有降低胆固醇含量的作用。法国科研人员经过试验得出：吃苹果可以减少血液中胆固醇含量，增加胆汁分泌和胆汁酸功能，因而可避免胆固醇沉淀在胆汁中形成胆结石。
本发明的西红柿的功效有：
美容护肤抗衰老：
西红柿里含有大量的维生素，具有美容的功效，将西红柿洗净捣烂取汁，加一些白糖，就成为面膜了，敷在脸上，能让你的皮肤变细腻光滑，防衰老。
治贫血：
苹果和西红柿各一个，取芝麻15克，一次性吃下，每天坚持吃一次，坚持一段时间就可以治疗贫血。
治疗皮肤病：
取新鲜西红柿，去皮、去籽，然后捣烂，敷在患处，可以治疗真菌性皮肤病和感染性皮肤病。
治疗牙龈出血：
经常牙龈出血的时候，每天吃一个西红柿，当成水果来吃，吃半个月。
治疗肝炎：
西红柿洗净切丁，取一匙，胡萝卜、芹菜洗净切碎，猪油半匙，锅加水、粳米，煮成粥，倒入上面其他的材料，煮熟，加盐、味精调味即可。能治疗肝炎。
防癌：
西红柿里的营养很丰富，每天吃鲜熟的西红柿，能起到防癌的作用，同时能辅助治疗癌症，清热解毒，抑制病变。
本发明的虎菌主要功效：小孩咳嗽，长年咳嗽，发热，胃病，肺气肿，支气管炎，清热解毒，它是家中必备良药，虎奶菌对慢性、过敏性、虚寒型顽咳、小儿咳嗽、哮喘有神奇疗效，可提高体质、免疫力、智力、防痴呆，消除肺部的污染物。虎菌它是一种食用菌，平时也可以保健食用，味道清淡，可以煮水喝，也可以泡软后剁瘦肉炖汤。
本发明的猴头菌性平、味甘。利五脏，助消化;具有健胃，补虚，抗癌，益肾精之功效;具体猴头菌的功效与作用有：
猴头菌主治食少便溏、胃及十二指肠溃疡、神经衰弱、食道癌、胃癌、眩晕、阳痿等病症。年老体弱者食用猴头菌，有滋补强身的作用。
猴头菌是一种高蛋白、低脂肪、富含矿物质和维生素的一种优良食品;
猴头菌含不饱和脂肪酸，能降低血胆固醇和甘油三酯含量，调节血脂，利于血液循环，是心血管患者的理想食品;
猴头菌含有的多糖体、多肽类及脂肪物质，能抑制癌细胞中遗传物质的合成，从而预防和治疗消化道癌症和其他恶性肿瘤;
猴头菌中含有多种氨基酸和丰富的多糖体，能助消化，对胃炎、胃癌、食道癌、胃溃疡、十二指肠溃疡等消化道疾病的疗效令人瞩目;
猴头菌具有提高肌体免疫力的功能，可延缓衰老。
服用猴头菌对于轻度失眠不失为较好的辅助治疗。另外，失眠患者应该培养起较好的生活习惯，如晚饭后多散步，平常多运动，还应该调整工作习惯培养工作兴趣，以积极的心态投入工作当中去。这些对于症状的恢复均有很好的帮助。
长期以来，人们把它与燕窝相提并论。猴头菌有很好的滋补作用，能治疗消化不良、胃溃疡、十二指肠溃疡、神经衰弱等疾病，民间有“多食猴头，返老还童”之说。
本发明的蜜环菌对治疗眩晕、脑供血不足、椎基底供血不足、美尼尔、耳石症等等有作用；蜜环菌能够提高大脑、颈椎基底血管的供血供氧能力，恢复血管弹性，促进血液循环；解决因供血供氧不足导致的头痛头晕、恶心呕吐等情况。
附图说明
图1是本发明实施例提供的抗癌、抗肿瘤的生态富硒发酵饮料的制备方法流程图。
具体实施方式
为了使本发明的目的、技术方案及优点更加清楚明白，以下结合实施例，对本发明进行进一步详细说明。应当理解，此处所描述的具体实施例仅仅用以解释本发明，并不用于限定本发明。
人们在日常摄取的硒含量不足，市场上缺少一种利用有机生态硒粉及中草药和有益菌制作食物饮品，来为人们抗癌、抗肿瘤、降三高、抗氧化提供帮助；
本发明实施例提供的抗癌、抗肿瘤的生态富硒发酵饮料，按质量计由
有机生态硒粉0.25~1 KG、茶叶0.5~2Kg、牛樟芝0.25~1 KG、金藏花0.25~1 KG、灰树花0.25~1 KG、茯苓0.5~2.5 KG、玉竹0.5~5 KG、松露0.25~1.5 KG、蛹虫草0.5~2.5 KG、大豆0.5~2.5 KG、虎菌0.5-6 KG、猴头菌0.5~2.5 KG、蜜环菌0.5~4 KG、香菇0.5~2.5 KG、苹果0.5~15 KG、梨子0.5~15 KG、香蕉0.5~10 KG、橙子0.5~10 KG、胡萝卜0.5~5 KG、西红柿0.5~5KG、黑糖0.5~10 KG及水100KG组成。
本发明的虎菌、猴头菌、蜜环菌均为市购产品。
图1所示，本发明实施例提供的抗癌、抗肿瘤的生态富硒发酵饮料的制备方法，包括：
S101：混合，将所有材料按比例混合。
S102：装罐，将混合物放入高位罐加入常温纯净水。
S103：发酵，让产品经过六个月的全封闭式紫外线消毒，杀菌，发酵。
S104:过滤，将残渣排除，只留下发酵液。
S105：杀菌，将发酵液进行杀菌处理。
S106：包装，将发酵液装入玻璃瓶封口、打包。
本发明具有抗癌、抗肿瘤、降三高、抗氧化保健功效。
下面结合具体实施例对本发明作进一步描述。
实施例1
本发明实施例提供的抗癌、抗肿瘤的生态富硒发酵饮料，按质量计由
有机生态硒粉0.25KG、茶叶0.5Kg、牛樟芝0.25KG、金藏花0.25KG、灰树花0.25KG、茯苓0.5 KG、玉竹0.5KG、松露0.25KG、蛹虫草0.5 KG、大豆0.5KG、虎菌0.5KG、猴头菌0.5 KG、蜜环菌0.5KG、香菇0.5 KG、苹果0.5KG、梨子0.5 KG、香蕉0.5 KG、橙子0.5 KG、胡萝卜0.5KG、西红柿0.5 KG、黑糖0.5 KG及水100KG组成。具有抗癌、抗肿瘤、降三高、抗氧化保健功效。
实施例2
本发明实施例提供的抗癌、抗肿瘤的生态富硒发酵饮料，按质量计由
有机生态硒粉1 KG、茶叶2Kg、牛樟芝1 KG、金藏花1 KG、灰树花1 KG、茯苓2.5 KG、玉竹5 KG、松露01.5 KG、蛹虫草2.5 KG、大豆2.5 KG、虎菌6 KG、猴头菌2.5 KG、蜜环菌4 KG、香菇2.5 KG、苹果15 KG、梨子15 KG、香蕉10 KG、橙子10 KG、胡萝卜5 KG、西红柿5 KG、黑糖10KG及水100KG组成。具有抗癌、抗肿瘤、降三高、抗氧化保健功效。
实施例3
本发明实施例提供的抗癌、抗肿瘤的生态富硒发酵饮料，按质量计由
有机生态硒粉0.75 KG、茶叶1Kg、牛樟芝0.50 KG、金藏花0.65 KG、灰树花0.65KG、茯苓1.5 KG、玉竹2.5KG、松露1.0 KG、蛹虫草1.5 KG、大豆1.5KG、虎菌3.5 KG、猴头菌1.5KG、蜜环菌2.5 KG、香菇1.5 KG、苹果10KG、梨子10 KG、香蕉5.5KG、橙子6.5KG、胡萝卜2.5KG、西红柿2.5KG、黑糖6.5 KG及水100KG组成。具有抗癌、抗肿瘤、降三高、抗氧化保健功效。
以上所述仅为本发明的较佳实施例而已，并不用以限制本发明，凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等，均应包含在本发明的保护范围之内。
Claims (4)
1.一种抗癌、抗肿瘤的生态富硒发酵饮料，其特征在于，所述抗癌、抗肿瘤的生态富硒发酵饮料的组份按质量计由有机生态硒粉0.25~1 KG、茶叶0.5~2Kg、牛樟芝0.25~1 KG、金藏花0.25~1 KG、灰树花0.25~1 KG、茯苓0.5~2.5 KG、玉竹0.5~5 KG、松露0.25~1.5 KG、蛹虫草0.5~2.5 KG、大豆0.5~2.5 KG、虎菌0.5-6 KG、猴头菌0.5~2.5 KG、蜜环菌0.5~4 KG、香菇0.5~2.5 KG、苹果0.5~15 KG、梨子0.5~15 KG、香蕉0.5~10 KG、橙子0.5~10 KG、胡萝卜0.5~5 KG、西红柿0.5~5 KG、黑糖0.5~10 KG及水100KG组成。
2.如权利要求1所述的抗癌、抗肿瘤的生态富硒发酵饮料，其特征在于，所述抗癌、抗肿瘤的生态富硒发酵饮料的组份按质量计由
有机生态硒粉0.25KG、牛樟芝0.25KG、金藏花0.25KG、灰树花0.25KG、茯苓0.5 KG、玉竹0.5KG、松露0.25KG、蛹虫草0.5 KG、大豆0.5KG、虎菌0.5KG、猴头菌0.5 KG、蜜环菌0.5KG、香菇0.5 KG、苹果0.5KG、梨子0.5 KG、香蕉0.5 KG、橙子0.5 KG、胡萝卜0.5KG、西红柿0.5 KG、黑糖0.5 KG及水100KG组成。
3.如权利要求1所述的抗癌、抗肿瘤的生态富硒发酵饮料，其特征在于，所述抗癌、抗肿瘤的生态富硒发酵饮料的组份按质量计由有机生态硒粉1 KG、牛樟芝1 KG、金藏花1 KG、灰树花1 KG、茯苓2.5 KG、玉竹5 KG、松露01.5 KG、蛹虫草2.5 KG、大豆2.5 KG、虎菌6 KG、猴头菌2.5 KG、蜜环菌4 KG、香菇2.5 KG、苹果15 KG、梨子15 KG、香蕉10 KG、橙子10 KG、胡萝卜5 KG、西红柿5 KG、黑糖10 KG及水100KG组成。
4.如权利要求1所述的抗癌、抗肿瘤的生态富硒发酵饮料，其特征在于，所述抗癌、抗肿瘤的生态富硒发酵饮料的组份按质量计由有机生态硒粉0.75 KG、牛樟芝0.50 KG、金藏花0.65 KG、灰树花0.65KG、茯苓1.5 KG、玉竹2.5KG、松露1.0 KG、蛹虫草1.5 KG、大豆1.5KG、虎菌3.5 KG、猴头菌1.5KG、蜜环菌2.5 KG、香菇1.5 KG、苹果10KG、梨子10 KG、香蕉5.5KG、橙子6.5KG、胡萝卜2.5KG、西红柿2.5KG、黑糖6.5 KG及水100KG组成。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810855024.3A CN108835321A (zh) | 2018-07-31 | 2018-07-31 | 一种抗癌、抗肿瘤的生态富硒发酵饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810855024.3A CN108835321A (zh) | 2018-07-31 | 2018-07-31 | 一种抗癌、抗肿瘤的生态富硒发酵饮料 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108835321A true CN108835321A (zh) | 2018-11-20 |
Family
ID=64195132
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810855024.3A Pending CN108835321A (zh) | 2018-07-31 | 2018-07-31 | 一种抗癌、抗肿瘤的生态富硒发酵饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108835321A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103027294A (zh) * | 2012-05-25 | 2013-04-10 | 深圳市中科海外科技有限公司 | 一种抗癌酵素及其制备方法 |
| CN104147383A (zh) * | 2014-07-26 | 2014-11-19 | 及长城 | 一种抗肿瘤的组合物及其制备方法 |
| CN105029594A (zh) * | 2015-08-26 | 2015-11-11 | 万长青 | 一种含硒酵素的保健饮料及其生产方法 |
| CN105815641A (zh) * | 2016-04-11 | 2016-08-03 | 厦门元之道生物科技有限公司 | 一种具有抗肿瘤活性的综合酵素液的制备方法及其用途 |
-
2018
- 2018-07-31 CN CN201810855024.3A patent/CN108835321A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103027294A (zh) * | 2012-05-25 | 2013-04-10 | 深圳市中科海外科技有限公司 | 一种抗癌酵素及其制备方法 |
| CN104147383A (zh) * | 2014-07-26 | 2014-11-19 | 及长城 | 一种抗肿瘤的组合物及其制备方法 |
| CN105029594A (zh) * | 2015-08-26 | 2015-11-11 | 万长青 | 一种含硒酵素的保健饮料及其生产方法 |
| CN105815641A (zh) * | 2016-04-11 | 2016-08-03 | 厦门元之道生物科技有限公司 | 一种具有抗肿瘤活性的综合酵素液的制备方法及其用途 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101816440B (zh) | 保健滋补油焖虾 | |
| KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
| CN105296584A (zh) | 一种海洋生物养生保健肽制剂的制备方法 | |
| CN106266700A (zh) | 一种沙棘组方袋泡型茶剂调配及制作方法 | |
| KR20130133946A (ko) | 한약재를 포함하는 된장 및 그의 제조방법 | |
| CN104479964A (zh) | 一种黄秋葵、菌、藻保健酒及其制备方法 | |
| CN109481589A (zh) | 一种治疗肺癌的排毒抗癌胶囊及食疗抗癌的制备方法 | |
| KR20100082689A (ko) | 월드 인삼 조성물과 그 제조방법 | |
| KR20170062755A (ko) | 한약재를 이용한 장어탕의 제조방법 | |
| CN102511876B (zh) | 山楂红枣浓浆及其生产工艺 | |
| CN107312691A (zh) | 一种豆角酒及其制备方法 | |
| CN101991110B (zh) | 野生灵芝系列食品 | |
| CN101921697A (zh) | 枸杞保健醋 | |
| CN104726320B (zh) | 一种无花果蜜醋及制作方法 | |
| CN114748583A (zh) | 一种滋补养生的中药药酒 | |
| CN102511868A (zh) | 一种添加维生素的红枣阿胶浓浆 | |
| CN108835321A (zh) | 一种抗癌、抗肿瘤的生态富硒发酵饮料 | |
| CN105595190A (zh) | 一种长寿豆酱 | |
| CN106307113A (zh) | 一种全营养羊肉捞饭肉汁及其制成的羊肉捞饭 | |
| CN110679935A (zh) | 一种牛蒡人参精华膏及其制备方法 | |
| KR102621081B1 (ko) | 조개 및 해산물류의 양념소스 제조방법 | |
| CN107361347A (zh) | 一种养生海参酱及其制备方法 | |
| CN106560088A (zh) | 一种全营养鹿肉捞饭肉汁及其制成的鹿肉捞饭 | |
| CN105211763A (zh) | 一种长寿竹筒豆酱的制备方法 | |
| CN104988046A (zh) | 一种抗炎滋补养颜金柑米醋及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181120 |